RDIF and ChemRar Launch Final Stage of Favipiravir Clinical Trial

- Median elimination of the virus in four days compared to nine days with standard therapy, according to the study involving 60 patients

- Efficacy of the drug is above 80%, a criterion of a drug with high antiviral activity

Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Friday, 22 May

Share |